The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

David J. Moliterno; Khaled M. Ziada

doi:10.1016/j.jacc.2007.10.025

The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Research output: Contribution to journal › Editorial

8 Scopus citations

Original language	English
Pages (from-to)	536-537
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	51
Issue number	5
DOIs	https://doi.org/10.1016/j.jacc.2007.10.025
State	Published - Feb 5 2008

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2007.10.025

Fingerprint

Dive into the research topics of 'The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.'. Together they form a unique fingerprint.

Cite this

Moliterno, D. J., & Ziada, K. M. (2008). The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology, 51(5), 536-537. https://doi.org/10.1016/j.jacc.2007.10.025

Moliterno, David J. ; Ziada, Khaled M. / The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. In: Journal of the American College of Cardiology. 2008 ; Vol. 51, No. 5. pp. 536-537.

@article{64daab6d126c45a68d14658da3e9f2ab,

title = "The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.",

author = "Moliterno, {David J.} and Ziada, {Khaled M.}",

year = "2008",

month = feb,

day = "5",

doi = "10.1016/j.jacc.2007.10.025",

language = "English",

volume = "51",

pages = "536--537",

number = "5",

}

Moliterno, DJ & Ziada, KM 2008, 'The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.', Journal of the American College of Cardiology, vol. 51, no. 5, pp. 536-537. https://doi.org/10.1016/j.jacc.2007.10.025

The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. / Moliterno, David J.; Ziada, Khaled M.
In: Journal of the American College of Cardiology, Vol. 51, No. 5, 05.02.2008, p. 536-537.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

AU - Moliterno, David J.

AU - Ziada, Khaled M.

PY - 2008/2/5

Y1 - 2008/2/5

UR - http://www.scopus.com/inward/record.url?scp=38349121568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349121568&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2007.10.025

DO - 10.1016/j.jacc.2007.10.025

M3 - Editorial

C2 - 18237681

AN - SCOPUS:38349121568

SN - 0735-1097

VL - 51

SP - 536

EP - 537

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 5

ER -

Moliterno DJ, Ziada KM. The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2008 Feb 5;51(5):536-537. doi: 10.1016/j.jacc.2007.10.025

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this